Browsing Topic

ASX PER

1 post
Muscular dystrophy

Percheron Therapeutics lays out expected timeline for avicursen trial data

Percheron expects to deliver topline data from its Duchenne muscular dystrophy (DMD) trial using avicursen from…
  • 2 mins
  • 02 December 2024 09:41 (AEDT)